Literature DB >> 3009614

Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice.

W F Davidson, F J Dumont, H G Bedigian, B J Fowlkes, H C Morse.   

Abstract

Lymph node cells from C3H mice homozygous for lpr and gld were compared for expression of cell surface antigens, lectin-binding sites, functional characteristics, expression of ecotropic MuLV, and organization of Ig and T cell receptor (TcR) beta-chain genes. The abnormal cells (Ly-2-/L3T4-) populating nodes of both mutant strains were specifically purified by using plate separation techniques. The purified abnormal cells were shown to express the beta-chain of the TcR, to exhibit rearrangements of the beta-chain genes, and to express TcR beta and alpha gene mRNA, demonstrating the T cell origin of these populations. FMF analyses of the separated abnormal cells showed them to be Thy-1+, Ly-1+, Ly-2-, L3T4-, Ly-5(B220)+, Ly-6+, Ly-22+, Ly-24+, sIg-, ThB-, Ia-, HSA-/+, and PC.1+ and to bind at high levels lectins that normally bind preferentially to B cells. These cells did not proliferate or generate CTL in response to stimulation with alloantigens, and supernatants of cells stimulated with Con A were devoid of IL 2. These characteristics do not correspond to those of any known immature or mature population of normal T cells. The findings that the abnormal T cells of lpr and gld homozygotes are indistinguishable for each parameter examined support the suggestion that these mutations may affect different enzymes in a common metabolic pathway of major importance to T cell differentiation and function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009614

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The lupus-prone BXSB strain: the Yaa gene model of systemic lupus erythematosus.

Authors:  R Merino; L Fossati; S Izui
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Adoptive transfer of the generalized lymphoproliferative disease (gld) syndrome in nude beige mice.

Authors:  S Froidevaux; N Rosenblatt; F Loor
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

4.  Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.

Authors:  M Makino; W F Davidson; T N Fredrickson; J W Hartley; H C Morse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 5.  Mouse chromosome 1.

Authors:  M F Seldin; T H Roderick; B Paigen
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 6.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

7.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

8.  Anti-IgM treatment of C57BL/6-1pr/1pr mice: depletion of B cells reduces 1pr gene-induced lymphoproliferation and mononuclear cell vasculitis.

Authors:  A Cerny; M Kimoto; A W Hügin; R Merino; S Izui
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

9.  Definition of a population of CD4-8- T cells that express the alpha beta T-cell receptor and respond to interleukins 2, 3, and 4.

Authors:  M Londei; A Verhoef; P De Berardinis; M Kissonerghis; B Grubeck-Loebenstein; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder.

Authors:  T Katagiri; K Urakawa; Y Yamanashi; K Semba; T Takahashi; K Toyoshima; T Yamamoto; K Kano
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.